🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study was an observational cohort study to investigate the efficacy pr...
Status
Unknown
Location
Min Jin
Start Date
2022-01-01
Trial ID
NCT05635149
Treatments Being Tested
This study aims to evaluate the efficacy and safety of the concurrent combi...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-05
Trial ID
NCT07591597
Treatments Being Tested
The expanded access program allows people to gain access to an unlicensed t...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT06195514
Treatments Being Tested
This study is designed to evaluate the safety, tolerability, and efficacy o...
Status
Not Yet Recruiting
Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2026-01-21
Trial ID
NCT07353268
Fruquintinib administered at 4 mg once daily in cycle 1 and 5 mg once daily...
Status
Withdrawn
Location
Guangdong General Hospital
Start Date
2018-05-08
Trial ID
NCT03684967
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, multi-center Phase ...
Status
Completed
Location
307 Hospital of PLA
Start Date
2014-05-29
Trial ID
NCT02590965
Treatments Being Tested
Fruquintinib is an oral tyrosine kinase inhibitor (TKI), which improves pro...
Status
Completed
Location
Zhongshan Hospital, Fudan University
Start Date
2021-01-01
Trial ID
NCT06202417
Treatments Being Tested
Fruquintinib (HMPL-013) is a novel oral small molecule that selectively inh...
Status
Completed
Location
Fudan University Cancer Center
Start Date
2011-01
Trial ID
NCT01645215
Treatments Being Tested
This is a single-arm, single-center, prospective phase I/II study that rece...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2023-12-28
Trial ID
NCT06115733
Treatments Being Tested
Colorectal cancer (CRC) is the fourth leading cause of cancer death worldwi...
Status
Active Not Recruiting
Location
Tianjin Cancer Hospital
Start Date
2023-07-01
Trial ID
NCT07491159